Labs see bottlenecks in France's plan to scale-up COVID-19 testing [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
Labs see bottlenecks in France's plan to scale-up COVID-19 testing PARIS (Reuters) - The leaders of two federations representing thousands of private laboratories across France cast doubt on the country’s ability to more than double coronavirus testing before the country begins unwinding its lockdown on May 11. The industry officials cited two looming bottlenecks: a potential shortage of workers able to conduct tests and the availability of government-approved reagents, with countries around the world racing to get hold of testing kits. Mass testing is critical to France’s ability to emerge safely from a now six-week old lockdown. France will switch to an aggressive doctrine on COVID-19 testing from May 11, aiming for 700,000 nasal swab tests per week, Prime Minister Edouard Philippe on Tuesday said. This means France must nearly triple its current capacity in just a fortnight. “I’m not sure this goal of 700,000 is reasonable,” Francois Blanchecotte, head of the Syndicat des Biologist
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.MarketBeat
- Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Weight Management Supplement Market Set to Soar at 14.2% CAGR through 2034 Amid Rising Prevalence of Obesity Globally | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website